首页> 外文期刊>The International journal of prosthodontics >Efficacy of an oral appliance for the treatment of obstructive sleep apnea.
【24h】

Efficacy of an oral appliance for the treatment of obstructive sleep apnea.

机译:口腔矫治器治疗阻塞性睡眠呼吸暂停的功效。

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of this study was to validate the use of a mandibular repositioner appliance (MRA) to treat obstructive sleep apnea (OSA) and primary snoring, comparing polysomnographic and Epworth Sleepiness Scale (ESS) data obtained prior to and during MRA treatment.Sixty-three patients who presented with different degrees of OSA severity or primary snoring were fitted to a PM positioner between 2009 and 2011. The diagnosis was established by a polysomnogram (PSG) prior to treatment and after 6 months to verify the efficacy of MRA therapy. Subjective daytime sleepiness was evaluated by ESS questionnaire prior to treatment and at the follow-up.Patients were divided into primary snoring and OSA groups. For the primary snoring group, PSG variables did not show significant results, except for a decrease in snoring. For the OSA group, the mean apnea-hypopnea index (AHI) was reduced from 23.0 ± 11 to 5.3 ± 4.0 and median ESS reduced significantly from 13.0 to 8.5. Complete response (AHI < 5) was found in 25 (40%) patients and partial response (AHI ≤ 10) in 27 (43%) patients.The findings validate the efficacy of the adjustable PM positioner for the safe treatment of OSA.
机译:这项研究的目的是通过比较在MRA治疗之前和治疗过程中获得的多导睡眠图和Epworth嗜睡量表(ESS)数据,验证使用下颌复位器(MRA)治疗阻塞性睡眠呼吸暂停(OSA)和原发性打s的情况。在2009年至2011年之间,将三位表现出不同程度的OSA严重程度或打的患者安装到PM定位器上。在治疗前和治疗6个月后通过多导睡眠图(PSG)进行诊断,以证实MRA治疗的有效性。在治疗前和随访时用ESS问卷评估主观白天的嗜睡程度。将患者分为打OS和OSA组。对于初级打s组,PSG变量除打ing减少外未显示明显结果。对于OSA组,平均呼吸暂停低通气指数(AHI)从23.0±11降低至5.3±4.0,中位ESS从13.0显着降低至8.5。在25名(40%)患者中发现完全缓解(AHI <5),在27名(43%)患者中发现部分缓解(AHI≤10)。这些发现验证了可调式PM定位器对OSA的安全治疗的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号